Insider Transactions

What Wave Life Sciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

	3 months	12 months
Open-market buys	0	6
Sells	4	47
Total trades	5	86

Shares traded

	3 months	12 months
Acquired	7,000	7,000
Disposed	23,996	23,996
Net activity	−16,996	−16,996

Common stock only — 81 reported trades in the last 12 months are in a security these totals do not cover.

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

All Buys Sells

Insider	Relation	Date	Transaction	Shares	Price	Value	Shares held
Rawcliffe Adrian	Director	Aug 12	Disclosed 10b5-1 sale · S	−12,700	$5.29	−$67.2K	0
Wagner Heidi L	Director	Aug 11	Disclosed 10b5-1 sale · S	−7,000	$6.01	−$42.1K	44,930
Wagner Heidi L	Director	Aug 11	Exercise / conversion · M	+7,000	$5.97	+$41.8K	51,930
Tan Aik Na	Director	Aug 11	Open-market sale · S	−432	$6.01	−$2.6K	24,968
Takanashi Ken	Director	Aug 11	Sale for tax withholding · S	−3,864	$6.01	−$23.2K	20,079
Ra Capital MANAGEMENT, L.p.	Director	Mar 30	Open-market buy · P	+971,091	$6.50	+$6.31M	26,975,505
Ra Capital MANAGEMENT, L.p.	Director	Mar 27	Open-market buy · P	+2,495,623	$6.43	+$16M	26,004,414
Ra Capital MANAGEMENT, L.p.	Director	Mar 26	Open-market buy · P	+351,224	$6.38	+$2.24M	23,508,791
Ra Capital MANAGEMENT, L.p.	Director	Mar 26	Open-market buy · P	+4,954,558	$6.06	+$30M	23,157,567
Takanashi Ken	Director	Mar 23	Derivative Conversion · C	+3,901,348	—	—	9,606,408
Francis Chris	See Remarks	Feb 26	Disclosed 10b5-1 sale · S	−15,294	$15.00	−$229K	61,867
Francis Chris	See Remarks	Feb 26	Exercise / conversion · M	+15,294	$4.75	+$72.6K	77,161
Francis Chris	See Remarks	Feb 26	Disclosed 10b5-1 sale · S	−17,900	$15.09	−$270K	61,867
Francis Chris	See Remarks	Feb 26	Exercise / conversion · M	+17,900	$3.87	+$69.3K	79,767
Moran Kyle	Chief Financial Officer	Feb 09	Open-market sale · S	−3,588	$13.45	−$48.3K	134,385
Francis Chris	See Remarks	Feb 09	Open-market sale · S	−1,883	$13.45	−$25.3K	61,867
Vargeese Chandra	See Remarks	Feb 09	Open-market sale · S	−3,228	$13.45	−$43.4K	408,246
Bolno Paul	President and CEO	Feb 09	Open-market sale · S	−10,480	$13.45	−$141K	275,520
Moran Kyle	Chief Financial Officer	Feb 05	Grant / award · A	+45,625	—	—	137,973
Francis Chris	See Remarks	Feb 05	Grant / award · A	+38,750	—	—	63,750

Page 1 of 15 · showing the 20 most recent Sign up free to view all 290 transactions and filter by insider →